Can Bactrim Cause Tremors or Shaking?
Yes, Bactrim (trimethoprim-sulfamethoxazole) can cause tremors and shaking, though this is an uncommon neurological adverse effect that occurs more frequently in immunocompromised patients and with high-dose therapy.
Evidence from FDA Drug Labeling
The FDA-approved drug label for Bactrim explicitly lists neurological adverse effects including "peripheral neuritis, ataxia, vertigo, tinnitus, headache" as well as "convulsions" and "aseptic meningitis" 1. While tremors are not specifically enumerated in the primary adverse reactions list, the documented neurological effects establish that Bactrim can affect the central and peripheral nervous systems.
Clinical Case Evidence
Direct evidence of tremor causation comes from published case reports:
A pediatric case documented high-frequency tremors and chorea in a 1.5-year-old immunocompromised child receiving high-dose TMP-SMX (120 mg/kg/day) for Pneumocystis pneumonia. The tremors resolved within 3 days of discontinuing the medication 2.
An adult case reported tremor development in a 29-year-old immunocompetent patient taking TMP-SMX, with resolution within 2 days after drug discontinuation 3. This case is particularly notable because it demonstrates that tremors can occur even in patients without immunocompromise, though the authors note CNS adverse effects occur "primarily in patients with acquired immune deficiency syndrome."
Clinical Context and Risk Factors
Higher risk scenarios include:
- High-dose therapy (particularly doses >15-20 mg/kg/day of the TMP component)
- Immunocompromised patients (HIV/AIDS, transplant recipients, cancer patients)
- Prolonged treatment duration
- Elderly patients with renal impairment
- Concurrent use of other CNS-active medications
Mechanism and Severity
The tremors appear to be:
- Dose-dependent (more common with higher doses)
- Reversible (typically resolve within 2-3 days of discontinuation)
- Part of a broader spectrum of CNS toxicity that can include ataxia, vertigo, and in severe cases, seizures
Clinical Management
If tremors develop:
- Assess severity and impact on function
- Check renal function (impaired clearance increases risk)
- Review concurrent medications for drug interactions
- Consider dose reduction if continuation is necessary
- Discontinue if tremors are severe or progressive
- Monitor for resolution (typically 2-3 days post-discontinuation)
Important caveat: The 2019 AGS Beers Criteria notes that TMP-SMX should be used with caution in older adults taking ACE inhibitors or ARBs due to hyperkalemia risk 4, and the 2016 methotrexate guidelines emphasize avoiding TMP-SMX with methotrexate due to severe toxicity risk 5. These drug interactions could potentially compound neurological adverse effects.
Bottom Line
While not among the most common adverse effects (which are gastrointestinal disturbances and skin reactions), tremors are a recognized neurological complication of Bactrim therapy. Clinicians should maintain awareness of this potential adverse effect, particularly when prescribing high doses or treating immunocompromised patients. The tremors are typically reversible upon drug discontinuation.